INSMED INC Depreciation
INSMED INC (INSM) reported Depreciation of $6.11 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- INSMED INC depreciation for the quarter ending 2026-06-30 was $3.18M, a 27.98% increase year-over-year.
- INSMED INC depreciation for the quarter ending 2026-03-31 was $2.93M, a 55.82% increase year-over-year.
- INSMED INC depreciation for the quarter ending 2025-12-31 was $3.62M, a 145.20% increase year-over-year.
- INSMED INC depreciation for the quarter ending 2025-09-30 was $2.46M, a 68.47% increase year-over-year.
- INSMED INC depreciation for fiscal 2025 was $10.45M, a 75.29% increase from fiscal 2024.
- INSMED INC depreciation for fiscal 2024 was $5.96M, a 7.85% increase from fiscal 2023.
- INSMED INC depreciation for fiscal 2023 was $5.53M, a 4.72% increase from fiscal 2022.
- INSMED INC depreciation for fiscal 2022 was $5.28M, a 42.19% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $6.11M 10-Q · filed 2026-08-06 | $9.74M derived: sum of 3 quarters · filed 2026-08-06 | $12.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.93M 10-Q · filed 2026-05-07 | $6.56M derived: sum of 2 quarters · filed 2026-05-07 | $9.02M derived: sum of 3 quarters · filed 2026-05-07 | $11.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $6.08M derived: sum of 2 quarters · filed 2026-02-19 | $8.57M derived: sum of 3 quarters · filed 2026-08-06 | $10.45M 10-K · filed 2026-02-19 |
| 2025-09-30 | $2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $4.94M derived: sum of 2 quarters · filed 2026-08-06 | $6.83M 10-Q · filed 2025-10-30 | $8.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.37M 10-Q · filed 2026-08-06 | $5.84M derived: sum of 3 quarters · filed 2026-08-06 | $7.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.88M 10-Q · filed 2026-05-07 | $3.36M derived: sum of 2 quarters · filed 2026-05-07 | $4.82M derived: sum of 3 quarters · filed 2026-05-07 | $6.26M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.94M derived: sum of 2 quarters · filed 2026-02-19 | $4.37M derived: sum of 3 quarters · filed 2026-02-19 | $5.96M 10-K · filed 2026-02-19 |
| 2024-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.90M derived: sum of 2 quarters · filed 2025-10-30 | $4.48M 10-Q · filed 2025-10-30 | $5.96M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.02M 10-Q · filed 2025-08-07 | $4.50M derived: sum of 3 quarters · filed 2026-02-19 | $5.99M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $1.59M 10-Q · filed 2025-05-08 | $3.06M derived: sum of 2 quarters · filed 2026-02-19 | $4.56M derived: sum of 3 quarters · filed 2026-02-19 | $5.87M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.97M derived: sum of 2 quarters · filed 2026-02-19 | $4.28M derived: sum of 3 quarters · filed 2026-02-19 | $5.53M 10-K · filed 2026-02-19 |
| 2023-09-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $2.80M derived: sum of 2 quarters · filed 2024-10-31 | $4.05M 10-Q · filed 2024-10-31 | $6.24M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.56M 10-Q · filed 2024-08-08 | $4.74M derived: sum of 3 quarters · filed 2025-02-20 | $5.59M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $1.25M 10-Q · filed 2024-05-09 | $3.43M derived: sum of 2 quarters · filed 2025-02-20 | $4.28M derived: sum of 3 quarters · filed 2025-02-20 | $5.24M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $3.03M derived: sum of 2 quarters · filed 2025-02-20 | $3.99M derived: sum of 3 quarters · filed 2025-02-20 | $5.28M 10-K · filed 2025-02-20 |
| 2022-09-30 | $851.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $1.81M derived: sum of 2 quarters · filed 2023-10-26 | $3.10M 10-Q · filed 2023-10-26 | $5.21M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $958.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.24M 10-Q · filed 2023-08-03 | $4.36M derived: sum of 3 quarters · filed 2024-02-22 | $6.60M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $1.29M 10-Q · filed 2023-05-04 | $3.40M derived: sum of 2 quarters · filed 2024-02-22 | $5.64M derived: sum of 3 quarters · filed 2024-02-22 | $8.03M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $4.36M derived: sum of 2 quarters · filed 2024-02-22 | $6.74M derived: sum of 3 quarters · filed 2024-02-22 | $9.13M 10-K · filed 2024-02-22 |
| 2021-09-30 | $2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $4.62M derived: sum of 2 quarters · filed 2022-10-27 | $7.01M 10-Q · filed 2022-10-27 | $9.33M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.77M 10-Q · filed 2022-08-04 | $7.09M derived: sum of 3 quarters · filed 2023-02-23 | $9.39M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $2.39M 10-Q · filed 2022-05-05 | $4.71M derived: sum of 2 quarters · filed 2023-02-23 | $7.00M derived: sum of 3 quarters · filed 2023-02-23 | $9.27M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $4.61M derived: sum of 2 quarters · filed 2023-02-23 | $6.88M derived: sum of 3 quarters · filed 2023-02-23 | $9.15M 10-K · filed 2023-02-23 |
| 2020-09-30 | $2.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $4.56M derived: sum of 2 quarters · filed 2021-10-28 | $6.83M 10-Q · filed 2021-10-28 | $8.77M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | $2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $4.53M 10-Q · filed 2021-08-05 | $6.47M derived: sum of 3 quarters · filed 2022-02-17 | $7.48M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $2.27M 10-Q · filed 2021-05-06 | $4.21M derived: sum of 2 quarters · filed 2022-02-17 | $5.21M derived: sum of 3 quarters · filed 2022-02-17 | $6.38M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $2.94M derived: sum of 2 quarters · filed 2022-02-17 | $4.12M derived: sum of 3 quarters · filed 2022-02-17 | $5.19M 10-K · filed 2022-02-17 |
| 2019-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $2.18M derived: sum of 2 quarters · filed 2020-10-29 | $3.25M 10-Q · filed 2020-10-29 | $4.17M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $2.25M 10-Q · filed 2020-08-06 | $3.17M derived: sum of 3 quarters · filed 2021-02-25 | $4.12M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $1.07M 10-Q · filed 2020-04-30 | $1.99M derived: sum of 2 quarters · filed 2021-02-25 | $2.95M derived: sum of 3 quarters · filed 2021-02-25 | $3.88M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $925.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.88M derived: sum of 2 quarters · filed 2021-02-25 | $2.81M derived: sum of 3 quarters · filed 2021-02-25 | $3.58M 10-K · filed 2021-02-25 |
| 2018-09-30 | $954.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $1.88M derived: sum of 2 quarters · filed 2019-10-30 | $2.65M 10-Q · filed 2019-10-30 | $3.38M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $929.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $1.70M 10-Q · filed 2019-08-01 | $2.43M derived: sum of 3 quarters · filed 2020-02-25 | $3.15M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $769.00K 10-Q · filed 2019-05-07 | $1.50M derived: sum of 2 quarters · filed 2020-02-25 | $2.22M derived: sum of 3 quarters · filed 2020-02-25 | $2.95M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $733.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.45M derived: sum of 2 quarters · filed 2020-02-25 | $2.19M derived: sum of 3 quarters · filed 2020-02-25 | $2.90M 10-K · filed 2020-02-25 |
| 2017-09-30 | $714.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $1.45M derived: sum of 2 quarters · filed 2018-10-30 | $2.17M 10-Q · filed 2018-10-30 | $2.85M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | $738.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $1.45M 10-Q · filed 2018-08-02 | $2.14M derived: sum of 3 quarters · filed 2019-02-22 | $2.81M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | $716.00K 10-Q · filed 2018-05-02 | $1.40M derived: sum of 2 quarters · filed 2019-02-22 | $2.07M derived: sum of 3 quarters · filed 2019-02-22 | $2.64M derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | $682.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $1.36M derived: sum of 2 quarters · filed 2019-02-22 | $1.92M derived: sum of 3 quarters · filed 2019-02-22 | $2.44M 10-K · filed 2019-02-22 |
| 2016-09-30 | $674.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $1.24M derived: sum of 2 quarters · filed 2017-11-02 | $1.76M 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $568.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $1.08M 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $514.00K 10-Q · filed 2017-05-03 | |||
| 2015-09-30 | $463.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $910.00K derived: sum of 2 quarters · filed 2016-11-03 | $1.34M 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $447.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $879.00K 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $432.00K 10-Q · filed 2016-05-05 | |||
| 2014-09-30 | $355.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $530.00K derived: sum of 2 quarters · filed 2015-11-06 | $697.00K 10-Q · filed 2015-11-06 | |
| 2014-06-30 | $175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $342.00K 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | $167.00K 10-Q · filed 2015-05-07 | |||
| 2012-12-31 | $600.00K 10-K · filed 2013-03-18 | |||
| 2011-12-31 | $300.00K 10-K · filed 2013-03-18 | |||
| 2010-12-31 | $100.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |